Aug 03, 2010, 02.27 PM IST

Kilitch Drugs (India) reports Rs 32.26 crore turnover for quarter ended Jun 2010

Kilitch Drugs (India) has reported a sales turnover of Rs 32.26 crore and a net profit of Rs 3.86 crore for the quarter ended Jun 2010

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Kilitch Drugs (India) reports Rs 32.26 crore turnover for quarter ended Jun 2010
Kilitch Drugs (India) has reported a sales turnover of Rs 32.26 crore and a net profit of Rs 3.86 crore for the quarter ended Jun 2010.
For the quarter ended Jun 2009 the sales turnover was Rs 23.31 crore and net profit was Rs 3.80 crore.
Quarterly Results of Kilitch Drugs (India)-------- in Rs. Cr. --------
Jun '09Mar '10Jun '10
Sales Turnover23.3149.8232.26
Other Income0.03----
Total Income23.3449.8232.26
Total Expenses16.2142.6225.16
Operating Profit7.107.207.10
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit7.137.207.10
Interest1.131.460.77
PBDT5.995.746.33
Depreciation1.602.901.51
Depreciation On Revaluation Of Assets------
PBT4.392.844.82
Tax0.590.830.96
Net Profit3.802.013.86
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share2.881.522.92
Book Value------
Equity13.2013.2013.20
Reserves------
Face Value10.0010.0010.00
Source : Religare Technova

Set email alert for

iPhone UI set for overhaul as details of a ‘black, white and flat’ iOS7 emerge
Araceli Roiz was not hired by me, I met her before she joined: Phaneesh Murthy "Araceli Roiz was not hired by me, I met her before she joined: Phaneesh Murthy"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 25 2013, 16:36

Expect Nifty to correct 60-70 points by expiry: Tulsian

- in MARKET OUTLOOK